Company Overview and News

 
Staying the course

2018-04-14 thestar.com.my
Mak: Our group wholesale banking practice however looks at clients holistically, based on their longer-term potential – not just in fair weather. Time will tell if our strategy has been correct.
Upvote Downvote

 
Global Forex Market

2018-04-07 thestar.com.my
THE US dollar was less volatile this week, gaining 0.5% to 90.142, despite trade tensions rattling markets as both trade rivals China and the United States fired at each other with tariff plans on critical trade items.
Upvote Downvote

 
CIMB targets RM200m in non-life insurance premiums this year

2018-04-03 themalaymailonline
CIMB Group Holdings Bhd is on track to achieve its target of RM200 million gross written premiums for its non-life insurance business this year. — Reuters picKUALA LUMPUR, April 3 — CIMB Group Holdings Bhd is on track to achieve its target of RM200 million gross written premiums for its non-life insurance business this year.
Upvote Downvote

 
E-wallet race heats up

2018-03-16 thestar.com.my
Early adopter: A man scans a QR code with his smartphone to purchase a drink from a vending machine in Guangzhou. China has been one of the earliest adopters of such a trend using mobile phones fitted with scannable quick-response codes which facilitate such transactions. — Bloomberg
Upvote Downvote

 
Digi and CIMB launch wireless card payment terminals

2018-03-12 thestar.com.my
PETALING JAYA: Digi Telecommunications Sdn Bhd has teamed up with CIMB Group Holdings Bhd to roll out its wireless payment terminals, where businesses can easily accept credit and debit card payments securely anytime, anywhere.
Upvote Downvote

 
Solid banking performance

2018-03-12 thestar.com.my
KUALA LUMPUR: Moody’s Investors Service says its six rated Malaysian banks showed a solid performance in 2017, with additional improvements likely in some areas in 2018, while asset quality will benefit from stronger macroeconomic conditions.
Upvote Downvote

 
Malaysian banks face risk on commercial real estate loans, says Moody’s

2018-03-12 themalaymailonline
The commercial real estate sector in Malaysia was a key concern for potential asset quality weakness, the credit rating agency said. — Ahmad ZamzahuriKUALA LUMPUR, March 12 — Malaysian banks face risks on their commercial real estate loans in 2018, although their overall asset quality is expected to remain stable on improving macroeconomic conditions and slower formation of new nonperforming loans, Moody’s said in a report.
Upvote Downvote

 
Moody’s sees Malaysian banks continuing solid performance in 2018

2018-03-12 themalaymailonline
The six banks in the report are Malayan Banking Bhd,CIMB Group Holdings Bhd, Public Bank Bhd, RHB Bank Bhd, Hong Leong Bank Bhd and AmBank (M) Bhd. — AFP picKUALA LUMPUR, March 12 — Moody’s Investors Service says its six rated Malaysian banks showed solid performance in 2017, with additional improvements likely in some areas in 2018.
Upvote Downvote

 
SE Asia stocks: Rise as pace of US rate hikes seen slowing after jobs data

2018-03-12 themalaymailonline
Malaysian shares rose about 0.7 per cent, with CIMB Group Holdings Bhd, up 1.4 per cent, contributing the most to the index gains. — Reuters picSINGAPORE, March 12 — South-east Asian stock markets rose today, tracking Asian peers, after chances of the US Federal Reserve hiking interest rates four times this year dimmed
Upvote Downvote

 
Moody's sees banks asset quality stabilise, profits improve

2018-03-12 thestar.com.my
Moody's said the asset quality and profitability of the six banks generally improved in 2017, while their capitalisation and funding remained adequate.
Upvote Downvote

 
Treasury Pulse

2018-03-10 thestar.com.my
DONALD Trump’s whole tariff fiasco heightened the volatility of the US dollar as it fluctuated between the week’s low of 89.618 and high of 90.179.
Upvote Downvote

 
Mixed fortunes for billionaire owners as stocks struggle to hold gains

2018-03-09 thestar.com.my
KUALA LUMPUR: Billionaire bankers and palm oil planters continue to see their wealth grow year-to-date, as the share price of their flagship companies outperformed the broader stock market rise, fuelled by strong earnings outlook.
Upvote Downvote

 
CIMB launches 1-Minute Home Financing InstaApproval

2018-03-06 themalaymailonline
CIMB has launched the 1-Minute Home Financing InstaApproval where consumers will get a faster, secure, paperless applications for home loans. — Reuters picKUALA LUMPUR, March 6 — CIMB Group Holdings Bhd launched its 1-Minute Home Financing InstaApproval today, promising loan approvals within a 60 seconds of the full submission of documents.
Upvote Downvote

 
Digital banking hits South-East Asia

2018-03-02 thestar.com.my
A NEW breed of digital-only banks are hitting South-East Asia. They are following the success of European digital pursuits by banking giants such as BNP Paribas in France and Virgin Money in the United Kingdom, which have invested heavily in technology to take on traditional high-street banks.
Upvote Downvote

 
Banks take cautious stance

2018-03-02 thestar.com.my
LOCAL banking groups wrapped up financial year 2017 (FY17) on an overall strong note but most are anticipating challenging times ahead, if some of their key targets set for this year are anything to go by.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...